학술논문

Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition.
Document Type
journal article
Source
AIDS (02699370); 7/17/2016, Vol. 30 Issue 11, p1703-1712, 10p
Subject
Language
ISSN
02699370